Solventum Corp Files 8-K on Operations

Ticker: SOLV · Form: 8-K · Filed: 2024-11-07T00:00:00.000Z

Sentiment: neutral

Topics: spin-off, corporate-structure, financial-reporting

Related Tickers: MMM

TL;DR

Solventum Corp, spun off from 3M, filed its initial 8-K detailing operations.

AI Summary

Solventum Corporation, formerly part of 3M Health Care Co., filed an 8-K on November 7, 2024, reporting on its results of operations and financial condition. The filing details its status as a newly independent entity incorporated in Delaware, with its principal executive offices located at 3M Center in St. Paul, Minnesota.

Why It Matters

This filing marks a significant corporate event for Solventum, detailing its operational and financial reporting as a standalone company following its separation from 3M.

Risk Assessment

Risk Level: low — This is a routine corporate filing providing information on operations and financial condition, not indicating immediate financial distress or significant new risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Solventum Corporation?

The primary purpose is to report on Solventum Corporation's results of operations and financial condition as a standalone entity.

When was this 8-K filed and what is the earliest event reported?

This 8-K was filed on November 7, 2024, and the earliest event reported is also November 7, 2024.

What was Solventum Corporation's former name?

Solventum Corporation's former name was 3M Health Care Co.

In which state is Solventum Corporation incorporated?

Solventum Corporation is incorporated in Delaware.

Where are Solventum Corporation's principal executive offices located?

Solventum Corporation's principal executive offices are located at 3M Center, Building 275-6W, East, Maplewood, Minnesota 55144.

From the Filing

0001964738-24-000040.txt : 20241107 0001964738-24-000040.hdr.sgml : 20241107 20241107161431 ACCESSION NUMBER: 0001964738-24-000040 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20241107 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241107 DATE AS OF CHANGE: 20241107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Solventum Corp CENTRAL INDEX KEY: 0001964738 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 922008841 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41968 FILM NUMBER: 241435906 BUSINESS ADDRESS: STREET 1: C/O 3M COMPANY STREET 2: 3M CENTER, BUILDING 275-6W-02 CITY: ST. PAUL STATE: MN ZIP: 55144-1000 BUSINESS PHONE: 651-733-1110 MAIL ADDRESS: STREET 1: C/O 3M COMPANY STREET 2: 3M CENTER, BUILDING 275-6W-02 CITY: ST. PAUL STATE: MN ZIP: 55144-1000 FORMER COMPANY: FORMER CONFORMED NAME: 3M Health Care Co DATE OF NAME CHANGE: 20230203 8-K 1 solv-20241107.htm 8-K solv-20241107 FALSE 0001964738 0001964738 2024-11-07 2024-11-07 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 7, 2024 SOLVENTUM CORPORATION (Exact Name of Registrant as Specified in Its Charter) Delaware File No. 001-41968 92-2008841 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 3M Center, Building 275-6W 2510 Conway Avenue East , Maplewood , Minnesota 55144 (Address of Principal Executive Offices) (Zip Code) (Registrant’s Telephone Number, Including Area Code) ( 651 ) 733-1110 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $.01 Per Share SOLV New York Stock Exchange Securities registered pursuant to section 12(g) of the Act: None Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company      ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the exchange Act.     ☐ Item 2.02. Results of Operations and Financial Condition On November 7, 2024, Solventum issued a press release reporting third-quarter financial results and updated its 2024 financial guidance (attached hereunder as Exhibit 99.1 and incorporated herein by reference). Item 9.01. Financial Statements and Exhibits (d) Exhibits Exhibit Number Description 99.1 Press Release, dated as of November 7 , 2024, of Solventum Corporation (furnished pursuant to Item 2.02 hereof) 104 Cover Page Interactive Data File (the cover page XBRL tag

View on Read The Filing